 |
|
|
| |
ONYX-I: Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Asian Adults with Genotype 1b Chronic Hepatitis C Virus Infection - A Randomized, Double-Blind, Placebo-Controlled Study
|
| |
| |
Reported by Jules Levin
26th Conference of the Asian Pacific Association for the Study of the Liver (APASL),
Shanghai, China. 16-19 Feb 2017
Lai Wei1, Jinlin Hou2, Yan Luo3, Jeong Heo4, Chi-Jen Chu5, Zhongping Duan6, Mong Cho7, Jun Cheng8, Jun Li9, Jidong Jia10, Wenjing Lu3, Tami Pilot-Matias3, Sarah Kopecky-Bromberg3, Niloufar Mobashery3, and Wan-Long Chuang11
1Peking University Peoples Hospital, Beijing; 2Nanfang Hospital, Guangzhou; 3AbbVie Inc., North Chicago, IL; 4Department of Internal Medicine, College of Medicine, Pusan National University and Medical Research Institute, Pusan National University Hospital, Busan; 5Taipei Veterans General Hospital, Taipei City; 6Beijing Youan Hospital Capital Medical University, Beijing; 7Pusan National University Yangsan Hospital, Yangsan; 8Beijing Di Tan Hospital, Capital Medical University, Beijing; 9Jiangsu Province Hospital, Nanjing, Jiangsu Province; 10Beijing Friendship Hospital, Capital Medical University, Beijing; 11Kaohsiung Medical University, Kaohsiung City
|
| |
|
|
|
|
|
